389 related articles for article (PubMed ID: 12086603)
1. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.
Taniguchi T; Garcia-Higuera I; Xu B; Andreassen PR; Gregory RC; Kim ST; Lane WS; Kastan MB; D'Andrea AD
Cell; 2002 May; 109(4):459-72. PubMed ID: 12086603
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.
Ho GP; Margossian S; Taniguchi T; D'Andrea AD
Mol Cell Biol; 2006 Sep; 26(18):7005-15. PubMed ID: 16943440
[TBL] [Abstract][Full Text] [Related]
3. Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage.
Castillo P; Bogliolo M; Surralles J
DNA Repair (Amst); 2011 May; 10(5):518-25. PubMed ID: 21466974
[TBL] [Abstract][Full Text] [Related]
4. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
5. Interaction of FANCD2 and NBS1 in the DNA damage response.
Nakanishi K; Taniguchi T; Ranganathan V; New HV; Moreau LA; Stotsky M; Mathew CG; Kastan MB; Weaver DT; D'Andrea AD
Nat Cell Biol; 2002 Dec; 4(12):913-20. PubMed ID: 12447395
[TBL] [Abstract][Full Text] [Related]
6. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract][Full Text] [Related]
7. The Fanconi anaemia genome stability and tumour suppressor network.
Bogliolo M; Cabré O; Callén E; Castillo V; Creus A; Marcos R; Surrallés J
Mutagenesis; 2002 Nov; 17(6):529-38. PubMed ID: 12435850
[TBL] [Abstract][Full Text] [Related]
8. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
9. Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.
Landais I; Hiddingh S; McCarroll M; Yang C; Sun A; Turker MS; Snyder JP; Hoatlin ME
Mol Cancer; 2009 Dec; 8():133. PubMed ID: 20043851
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
11. ATR couples FANCD2 monoubiquitination to the DNA-damage response.
Andreassen PR; D'Andrea AD; Taniguchi T
Genes Dev; 2004 Aug; 18(16):1958-63. PubMed ID: 15314022
[TBL] [Abstract][Full Text] [Related]
12. Mice lacking protein phosphatase 5 are defective in ataxia telangiectasia mutated (ATM)-mediated cell cycle arrest.
Yong W; Bao S; Chen H; Li D; Sánchez ER; Shou W
J Biol Chem; 2007 May; 282(20):14690-4. PubMed ID: 17376776
[TBL] [Abstract][Full Text] [Related]
13. The Fanconi anemia ID2 complex: dueling saxes at the crossroads.
Boisvert RA; Howlett NG
Cell Cycle; 2014; 13(19):2999-3015. PubMed ID: 25486561
[TBL] [Abstract][Full Text] [Related]
14. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
[TBL] [Abstract][Full Text] [Related]
15. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability.
Howlett NG; Taniguchi T; Durkin SG; D'Andrea AD; Glover TW
Hum Mol Genet; 2005 Mar; 14(5):693-701. PubMed ID: 15661754
[TBL] [Abstract][Full Text] [Related]
16. The interplay of Fanconi anemia proteins in the DNA damage response.
Wang X; D'Andrea AD
DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
[TBL] [Abstract][Full Text] [Related]
17. Activation of the S phase DNA damage checkpoint by mitomycin C.
Mladenov E; Tsaneva I; Anachkova B
J Cell Physiol; 2007 May; 211(2):468-76. PubMed ID: 17167777
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.
Siu WY; Lau A; Arooz T; Chow JP; Ho HT; Poon RY
Mol Cancer Ther; 2004 May; 3(5):621-32. PubMed ID: 15141020
[TBL] [Abstract][Full Text] [Related]
19. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the Fanconi anemia pathway by monoubiquitination.
Gregory RC; Taniguchi T; D'Andrea AD
Semin Cancer Biol; 2003 Feb; 13(1):77-82. PubMed ID: 12507559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
